$PLSH
Panacea Life Sciences Holdings Inc Stock $plsh

$plsh Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-Q Financial Statement

#000149315222031530 Filed on November 14, 2022

Income Statement

Concept	2022 Q4	2022 Q3	2021 Q3
Revenue	$324.8K	$366.2K	$588.0K
YoY Change	-49.72%	-37.72%	-13.27%
Cost Of Revenue	$1.534M	$318.9K	$1.555M
YoY Change	-29.88%	-79.5%	176.03%
Gross Profit	-$1.209M	$47.33K	-$967.4K
YoY Change	-21.56%	-104.89%	-944.69%
Gross Profit Margin	-372.22%	12.92%	-164.52%
Selling, General & Admin	$166.6K	$261.5K	$290.6K
YoY Change	-72.54%	-10.02%	-70.11%
% of Gross Profit		552.57%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$444.8K	$421.7K	$407.8K
YoY Change	8.26%	3.4%	-50.06%
% of Gross Profit		891.04%
Operating Expenses	$166.6K	$1.436M	$290.6K
YoY Change	-72.54%	394.09%	-70.11%
Operating Profit	-$1.376M	-$1.389M	-$1.258M
YoY Change	-35.96%	10.38%	46.65%
Interest Expense	-$387.1K	$597.9K	-$2.318M
YoY Change	135.97%	-125.8%	1070.59%
% of Operating Profit
Other Income/Expense, Net	$58.05K	-$1.305M	$248.8K
YoY Change	-73.8%	-624.7%
Pretax Income	-$1.705M	-$2.694M	-$3.090M
YoY Change	-18.46%	-12.81%	1.08%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$1.705M	-$2.694M	-$3.090M
YoY Change	-18.46%	-12.81%	63.79%
Net Earnings / Revenue	-524.84%	-735.55%	-525.43%
Basic Earnings Per Share		-$0.18	-$0.18
Diluted Earnings Per Share	-$0.11	-$181.3K	-$144.5K
COMMON SHARES
Basic Shares Outstanding	14.97M shares	14.97M shares	16.92M shares
Diluted Shares Outstanding		14.86M shares

Balance Sheet

Concept	2022 Q4	2022 Q3	2021 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.114M	$1.152M	$3.646M
YoY Change	-70.76%	-68.4%	6075.22%
Cash & Equivalents	$6.951K	$36.79K	$14.50K
Short-Term Investments	$1.107M	$1.116M	$3.632M
Other Short-Term Assets	$113.1K	$197.4K	$193.6K
YoY Change	-59.36%	1.97%	-71.55%
Inventory	$4.449M	$4.412M	$4.344M
Prepaid Expenses
Receivables	$206.1K	$221.9K	$515.1K
Other Receivables	$500.0K	$500.0K	$500.0K
Total Short-Term Assets	$6.382M	$6.484M	$9.200M
YoY Change	-29.85%	-29.52%	766.08%
LONG-TERM ASSETS
Property, Plant & Equipment	$7.676M	$7.965M	$12.65M
YoY Change	-13.17%	-37.03%	54304.09%
Goodwill	$2.189M	$2.189M
YoY Change	0.0%
Intangibles	$0.00	$15.35K
YoY Change	-100.0%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$13.11M	$13.50M	$14.91M
YoY Change	-10.75%	-9.48%	629.42%
TOTAL ASSETS
Total Short-Term Assets	$6.382M	$6.484M	$9.200M
Total Long-Term Assets	$13.11M	$13.50M	$14.91M
Total Assets	$19.49M	$19.98M	$24.11M
YoY Change	-18.06%	-17.13%	676.14%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$2.666M	$2.306M	$1.475M
YoY Change	58.15%	56.4%	-34.72%
Accrued Expenses	$2.090M	$1.974M	$4.963M
YoY Change	28.7%	-60.23%	509.51%
Deferred Revenue
YoY Change
Short-Term Debt	$10.32M	$9.535M	$6.315M
YoY Change	52.6%	50.98%	7994.41%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.07M	$13.81M	$12.75M
YoY Change	49.68%	8.33%	170.63%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change			-100.0%
Other Long-Term Liabilities	$3.573M	$3.531M	$3.043M
YoY Change	9.5%	16.06%	3435.08%
Total Long-Term Liabilities	$3.573M	$3.531M	$3.043M
YoY Change	9.5%	16.06%	944.72%
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.07M	$13.81M	$12.75M
Total Long-Term Liabilities	$3.573M	$3.531M	$3.043M
Total Liabilities	$21.63M	$20.42M	$15.80M
YoY Change	29.69%	29.31%	429.12%
SHAREHOLDERS EQUITY
Retained Earnings	-$25.90M	-$24.20M
YoY Change	54.49%
Common Stock	$1.497K	$1.496K
YoY Change	6.4%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$2.145M	-$439.9K	$8.319M
YoY Change
Total Liabilities & Shareholders Equity	$19.49M	$19.98M	$24.11M
YoY Change	-18.06%	-17.13%	676.14%

Cashflow Statement

Concept	2022 Q4	2022 Q3	2021 Q3
OPERATING ACTIVITIES
Net Income	-$1.705M	-$2.694M	-$3.090M
YoY Change	-18.46%	-12.81%	63.79%
Depreciation, Depletion And Amortization	$444.8K	$421.7K	$407.8K
YoY Change	8.26%	3.4%	-50.06%
Cash From Operating Activities	-$523.0K	-$711.1K	-$752.5K
YoY Change	-57.48%	-5.5%	33.65%
INVESTING ACTIVITIES
Capital Expenditures	$98.84K	-$127.4K
YoY Change	-160.66%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$244.1K
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$98.84K	-$127.4K	$244.1K
YoY Change	-1145.93%	-152.18%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	592.0K	838.7K	392.2K
YoY Change	-51.7%	113.84%	-35.03%
NET CHANGE
Cash From Operating Activities	-523.0K	-711.1K	-752.5K
Cash From Investing Activities	-98.84K	-127.4K	244.1K
Cash From Financing Activities	592.0K	838.7K	392.2K
Net Change In Cash	-29.84K	260.0	-116.2K
YoY Change	-666.22%	-100.22%	-385.88%
FREE CASH FLOW
Cash From Operating Activities	-$523.0K	-$711.1K	-$752.5K
Capital Expenditures	$98.84K	-$127.4K
Free Cash Flow	-$621.8K	-$583.7K
YoY Change	-41.72%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2021Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet		usd
CY2021Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther		usd
	PLSH	Noncash Fixed Asset Disposal As Part Of Reverse Acquisition NoncashFixedAssetDisposalAsPartOfReverseAcquisition		usd
	PLSH	Noncash Receivable Related Party NoncashReceivableRelatedParty		usd
	PLSH	Noncash Related Party Loan Repayment With Inventory NoncashRelatedPartyLoanRepaymentWithInventory		usd
	dei	Entity Central Index Key EntityCentralIndexKey	0001552189
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
CY2022Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain		usd
CY2022Q3	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet		usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet		usd
CY2022Q3	PLSH	Employer Retention Credit EmployerRetentionCredit		usd
CY2022Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2021Q3	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions		usd
CY2022Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices		usd
CY2021Q3	us-gaap	Stock Issued During Period Value Conversion Of Units StockIssuedDuringPeriodValueConversionOfUnits		usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets		usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium		usd
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition		usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	PLSH	Conversion Of Preferred Shares To Note Payable ConversionOfPreferredSharesToNotePayable		usd
	PLSH	Issuance Of Common Stock For Services Non Cash IssuanceOfCommonStockForServicesNonCash		usd
	PLSH	Liabilities From Acquisition Non Cash LiabilitiesFromAcquisitionNonCash		usd
	us-gaap	Notes Reduction NotesReduction		usd
	PLSH	Preferred Stock Series B One Non Cash PreferredStockSeriesBOneNonCash		usd
	PLSH	Preferred Stock Series B Two Non Cash PreferredStockSeriesBTwoNonCash		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod		shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
CY2021Q4	PLSH	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsAggregateIntrinsicValueOutstanding		usd
	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionGrantsInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised		shares
	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Exercised In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionExercisedInPeriodWeightedAverageExercisePrice
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Forfeitures And Expirations ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeituresAndExpirations		shares
	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Forfeited Or Expired In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionForfeitedOrExpiredInPeriodWeightedAverageExercisePrice
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	80121
	dei	City Area Code CityAreaCode	800
CY2022Q3	PLSH	Sharebased Compensation Arrangement By Sharebased Payment Award Non Option Equity Instruments Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionEquityInstrumentsAggregateIntrinsicValueOutstanding		usd
	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Vested And Exercisable In Period Weighted Average Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionVestedAndExercisableInPeriodWeightedAverageIntrinsicValue		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2022-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-38190
	dei	Entity Registrant Name EntityRegistrantName	Panacea Life Sciences Holdings, Inc.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	27-1085858
	dei	Entity Address Address Line1 EntityAddressAddressLine1	5910 S University Blvd
	dei	Entity Address Address Line2 EntityAddressAddressLine2	C18-193
	dei	Entity Address City Or Town EntityAddressCityOrTown	Greenwood Village
	dei	Entity Address State Or Province EntityAddressStateOrProvince	CO
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	10070886	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3078254	usd
	dei	Local Phone Number LocalPhoneNumber	985-0515
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2022Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	14965317	shares
CY2022Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	36791	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	19774	usd
CY2022Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	221919	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	244496	usd
CY2022Q3	us-gaap	Other Receivables OtherReceivables	500000	usd
CY2021Q4	us-gaap	Other Receivables OtherReceivables	500000	usd
CY2022Q3	us-gaap	Inventory Net InventoryNet	4412163	usd
CY2021Q4	us-gaap	Inventory Net InventoryNet	4264277	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1115542	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3791483	usd
CY2022Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	197421	usd
CY2021Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	278328	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	6483836	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	9098358	usd
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3331533	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3595100	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7964960	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8839982	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	15351	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	61401	usd
CY2022Q3	us-gaap	Goodwill Goodwill	2188810	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2188810	usd
CY2022Q3	us-gaap	Assets Assets	19984490	usd
CY2021Q4	us-gaap	Assets Assets	23783651	usd
CY2022Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	2306408	usd
CY2021Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	1685825	usd
CY2022Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1973684	usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1624090	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	8179801	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6441866	usd
CY2022Q3	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	1255886	usd
CY2021Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	220005	usd
CY2022Q3	PLSH	Paycheck Protection Loan PaycheckProtectionLoan	99100	usd
CY2021Q4	PLSH	Paycheck Protection Loan PaycheckProtectionLoan	99100	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	13814879	usd
CY2021Q4	us-gaap	Liabilities Liabilities	16681249	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3347335	usd
CY2022Q3	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3531264	usd
CY2021Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	3263028	usd
CY2022Q3	us-gaap	Liabilities Liabilities	20424397	usd
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2021Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2022Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14965317	shares
CY2022Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14965317	shares
CY2021Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14073708	shares
CY2021Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14073708	shares
CY2022Q3	us-gaap	Common Stock Value CommonStockValue	1496	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	1407	usd
CY2022Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23760704	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	23865155	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24202960	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16765013	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-439907	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7102402	usd
CY2022Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19984490	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23783651	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	366244	usd
CY2021Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	588040	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1302190	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	1413674	usd
CY2022Q3	us-gaap	Cost Of Revenue CostOfRevenue	318918	usd
CY2021Q3	us-gaap	Cost Of Revenue CostOfRevenue	305025	usd
	us-gaap	Cost Of Revenue CostOfRevenue	1016509	usd
	us-gaap	Cost Of Revenue CostOfRevenue	883508	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	47326	usd
CY2021Q3	us-gaap	Gross Profit GrossProfit	283015	usd
	us-gaap	Gross Profit GrossProfit	285681	usd
	us-gaap	Gross Profit GrossProfit	530166	usd
CY2022Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1174529	usd
CY2021Q3	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	1250434	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3635640	usd
	us-gaap	Operating Costs And Expenses OperatingCostsAndExpenses	3407407	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	261506	usd
CY2021Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	290638	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	926736	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	911906	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	1436035	usd
CY2021Q3	us-gaap	Operating Expenses OperatingExpenses	1541072	usd
	us-gaap	Operating Expenses OperatingExpenses	4562376	usd
	us-gaap	Operating Expenses OperatingExpenses	4319313	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1388709	usd
CY2021Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-1258057	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-4276695	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-3789147	usd
CY2022Q3	us-gaap	Interest Expense InterestExpense	597935	usd
CY2021Q3	us-gaap	Interest Expense InterestExpense	174727	usd
	us-gaap	Interest Expense InterestExpense	1669215	usd
	us-gaap	Interest Expense InterestExpense	781671	usd
CY2022Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-1446848	usd
CY2021Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2303218	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2651925	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	848533	usd
CY2021Q3	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	160296	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	22816	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	160296	usd
	us-gaap	Other Operating Income Expense Net OtherOperatingIncomeExpenseNet	27598	usd
CY2021Q3	PLSH	Employer Retention Credit EmployerRetentionCredit	190338	usd
	PLSH	Employer Retention Credit EmployerRetentionCredit	253791	usd
	PLSH	Employer Retention Credit EmployerRetentionCredit	190338	usd
CY2022Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	58046	usd
CY2021Q3	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	58410	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	174137	usd
	us-gaap	Rental Income Nonoperating RentalIncomeNonoperating	221328	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-297351	usd
CY2022Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	681546	usd
CY2021Q3	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	237202	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	681546	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	755782	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1305191	usd
CY2021Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1831699	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-3161252	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1097255	usd
CY2022Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2693900	usd
CY2021Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3089756	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-7437947	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2691892	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2693900	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3089756	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7437947	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2691892	usd
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
CY2021Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.18
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.50
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14862077	shares
CY2021Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16915706	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14862077	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	16915706	shares
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	2253993	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2693900	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-439907	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	7102402	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	55000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	-159362	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7437947	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	-439907	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	11485155	usd
CY2021Q3	us-gaap	Net Income Loss NetIncomeLoss	-3089756	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	8395399	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6708299	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	4378992	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2691892	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2691892	usd
CY2021Q3	us-gaap	Stockholders Equity StockholdersEquity	8395399	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7437947	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2691892	usd
	us-gaap	Depreciation Depreciation	1240281	usd
	us-gaap	Depreciation Depreciation	1280324	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	22816	usd
	us-gaap	Debt Securities Available For Sale Realized Gain DebtSecuritiesAvailableForSaleRealizedGain	160296	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-2651925	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	848533	usd
	us-gaap	Gains Losses On Sales Of Assets GainsLossesOnSalesOfAssets	-297351	usd
	PLSH	Non Cash Settlement Of Convertible Note And Accrued Interest NonCashSettlementOfConvertibleNoteAndAccruedInterest	253791	usd
	PLSH	Non Cash Settlement Of Convertible Note And Accrued Interest NonCashSettlementOfConvertibleNoteAndAccruedInterest	752751	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46050	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	46050	usd
	us-gaap	Amortization Of Debt Discount Premium AmortizationOfDebtDiscountPremium	876519	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-22577	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	367793	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	147886	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	628011	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-80907	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	166221	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	723521	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	955493	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	344080	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	344076	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1876580	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2692203	usd
	us-gaap	Proceeds From Previous Acquisition ProceedsFromPreviousAcquisition	9157	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	46832	usd
	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	230296	usd
	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	446026	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	144961	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	172397	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-98129	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	513082	usd
	PLSH	Proceeds From Payroll Protection Sba Loans ProceedsFromPayrollProtectionSBALoans	253791	usd
	PLSH	Proceeds From Payroll Protection Sba Loans ProceedsFromPayrollProtectionSBALoans	243041	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	17017	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-69879	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	637978	usd
	us-gaap	Repayments Of Related Party Debt RepaymentsOfRelatedPartyDebt	135000	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2375913	usd
	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	2001201	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1991726	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	2109242	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	19774	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	84379	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	36791	usd
CY2021Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14500	usd
	PLSH	Noncash Receivable Related Party NoncashReceivableRelatedParty	-500000	usd
	PLSH	Noncash Related Party Loan Repayment With Inventory NoncashRelatedPartyLoanRepaymentWithInventory	4693367	usd
	PLSH	Noncash Fixed Asset Disposal As Part Of Reverse Acquisition NoncashFixedAssetDisposalAsPartOfReverseAcquisition	3058457	usd
	PLSH	Conversion Of Preferred Shares To Note Payable ConversionOfPreferredSharesToNotePayable	385000	usd
	PLSH	Issuance Of Common Stock For Services Non Cash IssuanceOfCommonStockForServicesNonCash	55000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	220299	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	343979	usd
	PLSH	Liabilities From Acquisition Non Cash LiabilitiesFromAcquisitionNonCash	1096782	usd
	us-gaap	Notes Reduction NotesReduction	12718441	usd
	PLSH	Preferred Stock Series B One Non Cash PreferredStockSeriesBOneNonCash	150	usd
	PLSH	Preferred Stock Series B Two Non Cash PreferredStockSeriesBTwoNonCash	600	usd
	us-gaap	Stock Issued1 StockIssued1	4369085	usd
CY2022Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-24200000	usd
CY2022Q3	PLSH	Cash And Liquid Stock CashAndLiquidStock	1152000	usd
CY2021Q4	PLSH	Convertible Notes Payable And Warrant Financing ConvertibleNotesPayableAndWarrantFinancing	1100000	usd
CY2021Q4	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	1000000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p id="xdx_848_eus-gaap--UseOfEstimates_zgRAAb87rGPe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i><span id="xdx_86E_zCbX5oIXpQWh">Use of Estimates</span></i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Unaudited Condensed Consolidated Financial Statements have been prepared in conformity with US GAAP and required management of the Company to make estimates and assumptions in preparation of these statements. Actual results may differ significantly from those estimates. Significant estimates made by management include but are not limited to the useful life of property and equipment, incremental borrowing rate used in the calculation of right of use asset and lease liability, reserves for inventory, allowance for doubtful accounts, revenue allocations, valuation allowance on deferred tax assets, assumptions used in assessing impairment of long-term assets, assumptions used in the calculation of net realizable value of inventory and fair value of non-cash equity transactions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	10000	usd
CY2022Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	9144	usd
CY2022Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1115542	usd
CY2021Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3719483	usd
CY2022Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	3.29
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	46833	usd
	us-gaap	Debt Securities Available For Sale Realized Gain Loss DebtSecuritiesAvailableForSaleRealizedGainLoss	22816	usd
CY2021Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3791483	usd
	us-gaap	Proceeds From Sale Of Equity Securities Fv Ni ProceedsFromSaleOfEquitySecuritiesFvNi	46833	usd
	us-gaap	Equity Securities Fv Ni Unrealized Gain Loss EquitySecuritiesFvNiUnrealizedGainLoss	2629108	usd
CY2022Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	1115542	usd
	us-gaap	Finite Lived Intangible Asset Useful Life FiniteLivedIntangibleAssetUsefulLife	P5Y
CY2022Q3	us-gaap	Goodwill Goodwill	2188810	usd
CY2021Q4	us-gaap	Goodwill Goodwill	2188810	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	307001	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	307001	usd
CY2022Q3	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	291650	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	245600	usd
CY2022Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	15351	usd
CY2021Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	61401	usd
	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	In determining the leases classification, the Company assesses among other criteria: (i) 75% or more of the remaining economic life of the underlying asset is a major part of the remaining economic life of that underlying asset; and (ii) 90% or more of the fair value of the underlying asset comprises substantially all of the fair value of the underlying asset. Operating leases are included in operating lease right-of-use (“ROU”) assets, other current liabilities and long-term operating lease liabilities in the Company’s consolidated balance sheets. Finance leases are included in property, plant and equipment, net, other current liabilities, and long-term finance lease liabilities in the Company’s consolidated balance sheets.
CY2022Q3	PLSH	Customer Advances Payments CustomerAdvancesPayments	251125	usd
CY2021Q4	PLSH	Customer Advances Payments CustomerAdvancesPayments	24585	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24585	usd
CY2020Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	121300	usd
	PLSH	Payments Received For Unearned Revenue PaymentsReceivedForUnearnedRevenue	283591	usd
CY2021	PLSH	Payments Received For Unearned Revenue PaymentsReceivedForUnearnedRevenue	41465	usd
	PLSH	Revenue Earned Amount RevenueEarnedAmount	57051	usd
CY2021	PLSH	Revenue Earned Amount RevenueEarnedAmount	138180	usd
CY2022Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	251125	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	24585	usd
CY2021Q4	us-gaap	Stockholders Equity Reverse Stock Split StockholdersEquityReverseStockSplit	1-for-28 reverse stock split
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	5133541	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1862078	shares
CY2022Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	13058429	usd
CY2021Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	12702295	usd
CY2022Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	5093469	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	3862313	usd
CY2022Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7964960	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	8839982	usd
	us-gaap	Depreciation Depreciation	1240281	usd
	us-gaap	Depreciation Depreciation	1280324	usd
CY2022Q3	us-gaap	Depreciation Depreciation	421695	usd
CY2021Q3	us-gaap	Depreciation Depreciation	392485	usd
CY2022Q3	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	967523	usd
CY2021Q4	us-gaap	Inventory Raw Materials And Supplies InventoryRawMaterialsAndSupplies	970393	usd
CY2022Q3	us-gaap	Inventory Work In Process InventoryWorkInProcess	1671144	usd
CY2021Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1466763	usd
CY2022Q3	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1753521	usd
CY2021Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	1805779	usd
CY2022Q3	PLSH	Packaging Supplies PackagingSupplies	19975	usd
CY2021Q4	PLSH	Packaging Supplies PackagingSupplies	15549	usd
CY2022Q3	PLSH	Trading Goods TradingGoods	0	usd
CY2021Q4	PLSH	Trading Goods TradingGoods	5793	usd
CY2022Q3	PLSH	Inventories Net InventoriesNet	4412463	usd
CY2021Q4	PLSH	Inventories Net InventoriesNet	4264277	usd
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2030-12-31
	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2030-12-31
CY2022Q3	us-gaap	Lessee Operating Lease Term Of Contract LesseeOperatingLeaseTermOfContract	P3Y
CY2022Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3331533	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	3595100	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3434571	usd
CY2021Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	3692392	usd
CY2022Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3078254	usd
CY2021Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3347335	usd
CY2022Q3	PLSH	Shortterm Portion Of Operating Lease Liability ShorttermPortionOfOperatingLeaseLiability	356317	usd
CY2021Q4	PLSH	Shortterm Portion Of Operating Lease Liability ShorttermPortionOfOperatingLeaseLiability	345057	usd
CY2022Q3	PLSH	Unpaid Balance UnpaidBalance	1617359	usd
CY2021Q4	PLSH	Unpaid Balance UnpaidBalance	1279033	usd
CY2022Q3	PLSH	Operating Leases Liability Current OperatingLeasesLiabilityCurrent	1973676	usd
CY2021Q4	PLSH	Operating Leases Liability Current OperatingLeasesLiabilityCurrent	1624090	usd
CY2022Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P8Y3M
CY2021Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y
CY2021Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.030	pure
CY2022Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	114693	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	114693	usd
CY2021Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	344079	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	344079	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	112778	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	455622	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	460178	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	464780	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	469427	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1925123	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	3887908	usd
CY2022Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	453337	usd
CY2022Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	3434571	usd
CY2022Q3	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	8179801	usd
CY2021Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	6441866	usd
CY2022Q3	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	3531264	usd
CY2021Q4	us-gaap	Due To Other Related Parties Noncurrent DueToOtherRelatedPartiesNoncurrent	3263028	usd
CY2022Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	650000000	shares
CY2022Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	196491	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.51
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y2M12D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	196491	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	3.51
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y6M18D
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	196491	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	3.51
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y6M18D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	56377	shares
CY2021Q4	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Number Of Share ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageNumberOfShare	13.64
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P2Y3D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	275000	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	331377	shares
CY2022Q3	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Number Of Share ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageNumberOfShare	3.48
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Outstanding Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms	P3Y10M28D
CY2022Q3	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercisableNumber	331377	shares
CY2022Q3	PLSH	Share Based Compensation Arrangement By Share Based Payment Award Non Option Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionOutstandingWeightedAverageExercisePrice	3.48
	PLSH	Sharebased Compensation Arrangement By Sharebased Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm	P3Y10M28D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	107993	shares
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	107993	shares

Files In Submission

Name	View Source	Status
0001493152-22-031530-index-headers.html	Edgar Link	pending
0001493152-22-031530-index.html	Edgar Link	pending
0001493152-22-031530.txt	Edgar Link	pending
0001493152-22-031530-xbrl.zip	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
MetaLinks.json	Edgar Link	pending
plsh-20220930.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
plsh-20220930_lab.xml	Edgar Link	unprocessable
plsh-20220930_def.xml	Edgar Link	unprocessable
plsh-20220930_pre.xml	Edgar Link	unprocessable
plsh-20220930_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PLSH
Panacea Life Sciences Holdings Inc Stock $plsh

2022 Q4 Form 10-Q Financial Statement

#000149315222031530 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLSH Panacea Life Sciences Holdings Inc Stock $plsh

2022 Q4 Form 10-Q Financial Statement

#000149315222031530 Filed on November 14, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PLSH
Panacea Life Sciences Holdings Inc Stock $plsh